FT. COLLINS, Colo.--(BUSINESS WIRE)--InViragen today announced that the company will receive financial support from the Pediatric Dengue Vaccine Initiative (PDVI). The PDVI grant will provide funds for manufacture of Inviragen’s dengue vaccine in preparation for testing in human clinical trials.
